Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Millendo Therapeutics Inc (MLND)

Millendo Therapeutics Inc (MLND)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 96,432
  • Shares Outstanding, K 13,412
  • Annual Sales, $ 0 K
  • Annual Income, $ -27,190 K
  • 60-Month Beta 2.74
  • Price/Sales -507.54
  • Price/Cash Flow N/A
  • Price/Book 1.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.82
  • Number of Estimates 4
  • High Estimate -0.77
  • Low Estimate -0.93
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.10 +17.70%
on 10/09/19
7.39 -2.84%
on 09/20/19
+0.48 (+7.16%)
since 09/16/19
3-Month
4.56 +57.46%
on 09/03/19
11.33 -36.65%
on 07/17/19
-3.90 (-35.20%)
since 07/16/19
52-Week
4.56 +57.46%
on 09/03/19
17.34 -58.59%
on 04/08/19
-4.07 (-36.18%)
since 10/16/18

Most Recent Stories

More News
Will OvaScience Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in OvaScience.

MLND : 7.29 (+1.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade MLND with:

Business Summary

Millendo Therapeutics Inc. is a biopharmaceutical company. It focuses on developing novel treatments for orphan endocrine diseases. The company's product candidate consists of AZP-531 and ATR-101 which are in clinical stage. Millendo Therapeutics Inc., formerly known as OvaScience Inc., is based in Ann...

See More

Key Turning Points

2nd Resistance Point 7.50
1st Resistance Point 7.34
Last Price 7.29
1st Support Level 7.06
2nd Support Level 6.94

See More

52-Week High 17.34
Fibonacci 61.8% 12.46
Fibonacci 50% 10.95
Fibonacci 38.2% 9.44
Last Price 7.29
52-Week Low 4.56

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar